There were significant differences in clusterin, PTA, WBC, NC, LC, NLR, INR, TBIL, and incidences of HE and hepatorenal syndrome between HBV-non-ACLF and HBV-ACLF patients (P < 0.05, Table 1). This evidence concerns the gene CLU and Renal insufficiency.